Volume 1 · Issue 2
Precision Neurology
Clinical research on diagnosis, classification and biomarkers across epilepsy, neuroimmunology, headache and disorders of the peripheral nervous system.
100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief
Issue 2 · Reading list
Explore the research
100 readings · Page 2 of 5
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
Edgar Carnero Contentti, Jorge Correale
Journal of neuroinflammation · 2021
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, Simon A Broadley et al.
Frontiers in neurology · 2020
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg et al.
Journal of neurology · 2023
- Original article
Multiple sclerosis and neuroimmunology · CC BY 3.0
Demographic and clinical features of neuromyelitis optica: A review.
L Pandit, N Asgari, M Apiwattanakul, J Palace et al.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2015
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Sven Jarius, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl et al.
Journal of neurology · 2023
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, Ke Shang et al.
Signal transduction and targeted therapy · 2023
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
Giordani Rodrigues Dos Passos, Luana Michelli Oliveira, Bruna Klein da Costa, Samira Luisa Apostolos-Pereira et al.
Frontiers in neurology · 2018
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Anne-Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, Nicolas Collongues et al.
Journal of neuroinflammation · 2015
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Rosa Cortese, Ferran Prados Carrasco, Carmen Tur, Alessia Bianchi et al.
Neurology · 2022
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
Silke Häusser-Kinzel, Martin S Weber
Frontiers in immunology · 2019
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.
Karol Estrada, Christopher W Whelan, Fengmei Zhao, Paola Bronson et al.
Nature communications · 2018
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
Samira Saadoun, Patrick Waters, Gregory P Owens, Jeffrey L Bennett et al.
Acta neuropathologica communications · 2014
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Cognitive impairment in multiple sclerosis: diagnosis and monitoring.
Virginia Meca-Lallana, Francisco Gascón-Giménez, Ricardo C Ginestal-López, Yolanda Higueras et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis.
Fulin Gao, Bingyan Chai, Cheng Gu, Ruipeng Wu et al.
BMC neurology · 2019
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Robert Wilson, Mateusz Makuch, Anne-Kathrin Kienzler, James Varley et al.
Brain : a journal of neurology · 2018
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Patrick Schindler, Ulrike Grittner, Johanna Oechtering, David Leppert et al.
Journal of neuroinflammation · 2021
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Michalina Jasiak-Zatonska, Alicja Kalinowska-Lyszczarz, Slawomir Michalak, Wojciech Kozubski
International journal of molecular sciences · 2016
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.
Agnieshka M Agasing, Qi Wu, Bhuwan Khatri, Nadja Borisow et al.
Nature communications · 2020
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes.
Marco A Lana-Peixoto, Natália Talim
Biomedicines · 2019
- Original article
Multiple sclerosis and neuroimmunology · CC BY 4.0
B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4.
Ali Maisam Afzali, Lucy Nirschl, Christopher Sie, Monika Pfaller et al.
Nature · 2024
